Seeking Alpha

QualityStocks'  Instablog

QualityStocks
Send Message
QualityStocks (www.qualitystocks.net) assists publicly traded companies by getting their story out to the investment community while helping investors discover emerging companies with plenty of growth potential. Our name, QualityStocks, emphasizes our commitment to connect subscribers with... More
My company:
QualityStocks
My blog:
QualityStocks Micro-Cap and Small-Cap Blog
  • CEO Of MELA Sciences, Inc. (MELA) Resigns, Robert Coradini To Fill In Temporarily 0 comments
    Jun 17, 2013 2:05 PM | about stocks: MELA

    MELA Sciences, a medical device company and developer of MelaFind(NYSE:R), announced today that Joseph Gulfo has resigned as Chairman, President, Chief Executive Officer, and member of the Board of Directors. Member of the Board of Directors since December 2011, Robert Coradini will serve as interim CEO while the board hunts for a new Chief Executive Officer. Coradini has over 20 years of experience in the health care industry both leading and managing businesses for Johnson & Johnson and GE Medical Systems, now known as GE Healthcare.

    While at Johnson & Johnson, Coradini held a variety of senior leadership positions. Acting as President of various subsidiaries of J&J, including Lifescan, Cordis Endovascular, and Cardiovations (Ethicon), Coradini was the head of business development of the Medical Devices & Diagnostics Group. Most recently he sat as President of New Ventures for the Johnson & Johnson Consumer Group of Companies, overseeing the OrthoNeutrogena division, now known as Ortho Dermatologics after being acquired by Valeant International.

    "We are thankful for Joseph's leadership over the past nine years as the company has undergone a successful transformation from product development, to FDA Approval, to early commercial launch of MelaFind(R) in the US and Germany," stated Coradini. "The Board and I believe in the technology as a major advance for dermatologists in their fight against Melanoma. It is our intent to work closely with these physicians to succeed. We wish Joseph the best in the next phase of his career."

    Resulting from these recent changes, David Stone who has served as Lead Independent Director will assume the role of Chairman of the board. In addition he will lead the search for Gulfo's replacement.

    MELA Sciences is currently focused on the commercialization of FDA-approved MelaFind(R). To learn more, visit melasciences.com

    Please see disclaimer on the QualityStocks website: disclaimer.qualitystocks.net

    Stocks: MELA
Back To QualityStocks' Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (0)
Track new comments
Be the first to comment
Full index of posts »
Latest Followers

StockTalks

More »
Posts by Themes
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.